Published: Jul, 2018

The global market for peptide therapeutics is competitive in nature with a moderate level of consolidation, states a new market research study by Transparency Market Research. The leading players in the market are focusing on research and development activities, which are anticipated to generate promising growth opportunities for the market players in the next few years. Some of the leading players operating in the peptide therapeutics market across the globe are Eli Lilly, Teva, Novo Nordisk, and Sanofi. In addition to this, the growing emphasis on innovations and development of new techniques are some of the other key factors that are predicted to accelerate the growth of the overall market and enhance the competitive environment in the next few years. Furthermore, technological advancements in this field is another major factor encouraging the competition among the key players in the near future.

According to the market research study by Transparency Market Research, in 2015, the global market for peptide therapeutics was worth US$ 21.3 bn and is projected to reach a value of US$ 46.6 bn by the end of 2024. The market is predicted to register a promising 9.10% CAGR between 2016 and 2024.

peptide therapeutics marketPresence of Leading Players to Drive North America Peptide Therapeutics Market

The global market for peptide therapeutics has been classified on the basis of geography, among which North America is anticipated to account for a large share of the global market in the next few years. In the last few years, this region led the global market and is projected to remain in the similar position in the near future. The high growth of this region can be attributed to the rapid development of the healthcare infrastructure and the introduction of advanced peptide therapeutics. In addition to this, the presence of a large number of players operating in this region and the increasing emphasis on innovations and developments are some of the other factors that are projected to enhance the growth of the market in the near future.

The global market for peptide therapeutics has been categorized on the basis of application into drugs for metabolic disorders, central nervous systems therapeutics, respiratory disorder therapeutics, renal therapeutics, cancer treatment, gastrointestinal tract therapeutics, cardiovascular disease therapeutics, anti-infective drugs, and dermatology therapeutics. Among these, the cancer treatment segment is anticipated to witness a high growth in the next few years, owing to the rising focus of players on development of new products and drugs. In addition to this, technological advancements and the increasing research and development activities are some of the other factors that are predicted to encourage the growth of this segment in the next few years.

Global Market to Gain Traction with Rising Prevalence of Cancer 

The global market peptides therapeutics is anticipated to grow significantly throughout the forecast period. The increasing prevalence of cancer across the globe is one of the major factors anticipated to encourage the growth of the overall peptide therapeutics market in the next few years. The growing focus on technological advancements and innovations is predicted to generate potential growth opportunities for the market players in the next few years.

This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Peptide Therapeutics Market (Application - Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, and Renal; Route of Administration – Parenteral and Oral; Type - Innovative and Generic; Technology - Liquid Phase, Solid Phase, and Hybrid Phase; Type of Molecule - Vasopressin, Somatostatin, Calcitonin, and Natriuretic, Immunopeptide; API Peptide Type - In-house and CMO) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Key Takeaways:

  • Rapid development of the healthcare sector is one of the major factors anticipated to encourage the growth of the global peptide therapeutics market in the near future.
  • North America to lead the global peptide therapeutics market, further followed Europe and Asia Pacific.

The global peptide therapeutics market has been segmented as below:

Global Peptide Therapeutics Market Segmentation

  • By Application
    • Cancer
    • Metabolic
    • CVD
    • Respiratory
    • GIT
    • Anti-infective
    • Dermatology
    • CNS
    • Renal
    • Others
  • By Route of Administration
    • Parenteral
    • Oral
    • Others
    • By Type
    • Innovative
    • Generic
  • By Technology
    • Liquid Phase
    • Solid Phase
    • Hybrid Phase
  • By Type of Molecule
    • Vasopressin
    • Somatostatin
    • Calcitonin
    • Immunopeptide
    • Natriuretic
    • Others
  • By API Peptide Type
    • In-house
    • CMO
  • By Region
    • North America
      • US.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • Japan
      • China
      • India
      • Rest of APAC
    • Latin America (LATAM)
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • Rest of MEA
      • Middle East and Africa

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

.